期刊
CLINICAL INFECTIOUS DISEASES
卷 64, 期 9, 页码 1268-1270出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciw864
关键词
gyrA; Neisseria gonorrhoeae; ciprofloxacin; antibiotic resistance
资金
- David Geffen School of Medicine at UCLA
- National Institutes of Health [R21AI117256, R21AI109005]
Multidrug-resistant Neisseria gonorrhoeae is a top threat to public health. In November 2015, UCLA Health introduced a rapid gyrase A (gyrA) genotypic assay for prediction of Neisseria gonorrhoeae susceptibility to ciprofloxacin. We found a significant reduction in ceftriaxone use with a concomitant increase in targeted therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据